# NNRTI/PI Toxicity Switch to Darunavir Study

> **NCT00765154** · PHASE4 · TERMINATED · sponsor: **St Stephens Aids Trust** · enrollment: 12 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** darunavir
- **DRUG:** ritonavir

## Key facts

- **NCT ID:** NCT00765154
- **Lead sponsor:** St Stephens Aids Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-10
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Difficulties in recruitment due to a change in the nature of practice.
- **Last updated:** 2010-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00765154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00765154, "NNRTI/PI Toxicity Switch to Darunavir Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00765154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*